GENSCRIPT BIO (01548) issued 4.83 million shares due to the exercise of stock Options.

Zhitong Finance · Dec 10 18:36

GENSCRIPT BIO (01548) announced that the company will exercise Options on December 10, 2024, under the pre-listing share Options plan approved on July 15, 2015.

According to the announcement from Zhitong Finance APP, GENSCRIPT BIO (01548) issued 4.83 million shares as a result of exercising the Options on December 10, 2024, under the pre-listing share Options plan approved on July 15, 2015.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

金斯瑞生物科技(01548)因股份期权获行使而发行483万股

GENSCRIPT BIO (01548) issued 4.83 million shares due to the exercise of stock Options.

Risk Disclaimer

Statement